Ultraviolet Exposure, Antioxidant Use and Skin Erythema at Extreme High Altitude

This study has been completed.
Sponsor:
Collaborator:
Ontario Centres of Excellence
Information provided by:
Sunnybrook Health Sciences Centre
ClinicalTrials.gov Identifier:
NCT00685438
First received: May 22, 2008
Last updated: May 27, 2008
Last verified: May 2008

May 22, 2008
May 27, 2008
April 2007
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00685438 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Ultraviolet Exposure, Antioxidant Use and Skin Erythema at Extreme High Altitude
Observational Study of Skin Erythema by Spectrophotometer, and UV Exposure With Viospore Ultraviolet Monitors at Extreme Altitude (Mt. Everest, North Side)

With the increasing tourism and adventure travel into extreme environments comes the need to reassess the required protection against ultraviolet (UV) radiation and possible other oxidative stresses. This is an observational study of UV radiation exposure and skin erythema while at extreme altitude (Mt. Everest). In addition to UV exposure, skin erythema, antioxidant use (such as vitamins C and E) will be measured.

Hypothesis:   

  1. UV radiation at extreme altitude has larger effects on the skin than at sea level; therefore requiring an adjustment of the antioxidant use for adequate protection.
  2. The skin is an accurate reflection of UV and oxidative stress exposure
  3. The efficacy of oxidatives stress is reflective of the ethnicity of the individual.

The literature widely acknowledges the deleterious effects of UV radiation on skin health, via production of oxidative free radicals. Consequently, there have been numerous studies on the potential dermatological/anti-carcinogenic benefits of anti-oxidants, such as vitamins C and E, melatonin, green tea, zinc, and selenium. There is, however, a limited amount of literature on the quantity of UV exposure in high-risk settings, such as extreme altitude and equatorial zones. Currently, there is no literature on UV exposure on Mount Everest. Additionally, the efficacy of antioxidants (topical or systemic) has not yet been established in this environment.

This will be an observational study where the principal investigator will collect accumulated ultraviolet exposure at different extreme altitudes during a 6 week period of a summit expedition on the north side of Mt. Everest. Included in the data collection will be patient demographics, time, altitude, temperature, use of anti-oxidants, sunscreen (weighed), and skin erythema (spectophotometer).

Observational
Observational Model: Ecologic or Community
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

9 Mountaineers with intention to summit Everest (1 American, 1 British, 1 German, 5 Australians, 1 Asian-Australian) 4 Trekkers with intention to go to 7000m (2 Americans, 1 Asian, 1 British) 12 climbing sherpas (11 Nepali and 1 Tibetan)

  • Altitude
  • Ultraviolet Rays
  • Antioxidants
  • Oxidative Stress
  • Erythema
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
25
June 2007
Not Provided

Inclusion Criteria:

  • Participants part of the expedition who are willing to wear the monitor, and disclose information of diet/antioxidant supplements and topical sunblock.

Exclusion Criteria:

  • Participants who are unwilling to carry the UV monitor or disclose their demographics
Both
Not Provided
Yes
Contact information is only displayed when the study is recruiting subjects
Nepal
 
NCT00685438
005-2007
No
Ivy Cheng, Sunnybrook Health Sciences Center
Sunnybrook Health Sciences Centre
Ontario Centres of Excellence
Principal Investigator: Ivy S Cheng, MD Sunnybrook Hospital Emergency Department
Principal Investigator: Lothar D Lilge, PhD Ontario Cancer Institute
Sunnybrook Health Sciences Centre
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP